Clinical Trial Update: Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) [Phase 2]

View source ↗

Summary

CHIMERA is a Phase 2 trial evaluating induction chemotherapy plus immunotherapy in patients with resectable epithelioid and biphasic pleural mesothelioma; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Mesothelioma

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Pleural Mesothelioma | Phase 2 | Status: ACTIVE_NOT_RECRUITING